X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs UNICHEM LAB - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH UNICHEM LAB STERLING BIOTECH/
UNICHEM LAB
 
P/E (TTM) x -0.3 -63.1 - View Chart
P/BV x 0.0 0.7 1.9% View Chart
Dividend Yield % 0.0 2.4 -  

Financials

 STERLING BIOTECH   UNICHEM LAB
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
UNICHEM LAB
Mar-18
STERLING BIOTECH/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs11382 2.7%   
Low Rs3234 1.5%   
Sales per share (Unadj.) Rs26.8116.3 23.1%  
Earnings per share (Unadj.) Rs-15.0-18.9 79.0%  
Cash flow per share (Unadj.) Rs-5.5-11.7 46.5%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %01.6 0.0%  
Book value per share (Unadj.) Rs54.9381.0 14.4%  
Shares outstanding (eoy) m267.8770.34 380.8%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.32.6 9.8%   
Avg P/E ratio x-0.5-16.3 2.9%  
P/CF ratio (eoy) x-1.3-26.2 4.8%  
Price / Book Value ratio x0.10.8 15.7%  
Dividend payout %0-26.4 0.0%   
Avg Mkt Cap Rs m1,86221,668 8.6%   
No. of employees `0001.42.3 59.4%   
Total wages/salary Rs m5472,006 27.3%   
Avg. sales/employee Rs Th5,303.33,587.8 147.8%   
Avg. wages/employee Rs Th403.8880.0 45.9%   
Avg. net profit/employee Rs Th-2,959.0-583.7 506.9%   
INCOME DATA
Net Sales Rs m7,1818,180 87.8%  
Other income Rs m43610 7.0%   
Total revenues Rs m7,2238,790 82.2%   
Gross profit Rs m947-1,320 -71.7%  
Depreciation Rs m2,543505 503.5%   
Interest Rs m4,37780 5,464.5%   
Profit before tax Rs m-5,931-1,295 457.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,92433 -5,757.9%   
Profit after tax Rs m-4,007-1,331 301.0%  
Gross profit margin %13.2-16.1 -81.7%  
Effective tax rate %32.4-2.6 -1,257.5%   
Net profit margin %-55.8-16.3 342.9%  
BALANCE SHEET DATA
Current assets Rs m14,33523,318 61.5%   
Current liabilities Rs m49,8094,635 1,074.6%   
Net working cap to sales %-494.0228.4 -216.3%  
Current ratio x0.35.0 5.7%  
Inventory Days Days403122 331.3%  
Debtors Days Days171121 140.5%  
Net fixed assets Rs m55,4328,163 679.0%   
Share capital Rs m268141 190.4%   
"Free" reserves Rs m13,93526,660 52.3%   
Net worth Rs m14,70126,801 54.9%   
Long term debt Rs m9,4783 287,207.6%   
Total assets Rs m73,98831,890 232.0%  
Interest coverage x-0.4-15.2 2.3%   
Debt to equity ratio x0.60 523,588.0%  
Sales to assets ratio x0.10.3 37.8%   
Return on assets %0.5-3.9 -12.8%  
Return on equity %-27.3-5.0 548.8%  
Return on capital %-6.4-4.5 141.5%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Exports (fob) Rs m1,860NA-   
Imports (cif) Rs m12NA-   
Fx inflow Rs m1,8604,356 42.7%   
Fx outflow Rs m250-   
Net fx Rs m1,8354,356 42.1%   
CASH FLOW
From Operations Rs m1,719-1,123 -153.0%  
From Investments Rs m-3,14816,487 -19.1%  
From Financial Activity Rs m1,426-8,811 -16.2%  
Net Cashflow Rs m-36,552 -0.1%  

Share Holding

Indian Promoters % 33.9 50.1 67.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 15.1 -  
FIIs % 9.9 3.0 330.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 31.7 124.0%  
Shareholders   21,482 20,176 106.5%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   FDC LTD.  ALEMBIC LTD  WYETH LTD  AJANTA PHARMA  SUVEN LIFE  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Positive Note; Banking and Healthcare Stocks Witness Buying Interest(Closing)

Indian share markets ended their session on a positive note today. Gains were largely seen in the banking sector and healthcare sector.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Sep 24, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - TTK HEALTHCARE COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS